Experiment: 2L83

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	100mM sodium chloride-1; 20mM sodium phosphate-2; 90% H2O/10% D2O	90% H2O/10% D2O	0.12	6.5	ambient	293
2	3D CBCA(CO)NH	100mM sodium chloride-1; 20mM sodium phosphate-2; 90% H2O/10% D2O	90% H2O/10% D2O	0.12	6.5	ambient	293
3	3D C(CO)NH	100mM sodium chloride-1; 20mM sodium phosphate-2; 90% H2O/10% D2O	90% H2O/10% D2O	0.12	6.5	ambient	293
4	3D HNCO	100mM sodium chloride-1; 20mM sodium phosphate-2; 90% H2O/10% D2O	90% H2O/10% D2O	0.12	6.5	ambient	293
5	3D HNCACB	100mM sodium chloride-1; 20mM sodium phosphate-2; 90% H2O/10% D2O	90% H2O/10% D2O	0.12	6.5	ambient	293
6	3D HBHA(CO)NH	100mM sodium chloride-1; 20mM sodium phosphate-2; 90% H2O/10% D2O	90% H2O/10% D2O	0.12	6.5	ambient	293
7	3D HN(CO)CA	100mM sodium chloride-1; 20mM sodium phosphate-2; 90% H2O/10% D2O	90% H2O/10% D2O	0.12	6.5	ambient	293
8	3D H(CCO)NH	100mM sodium chloride-1; 20mM sodium phosphate-2; 90% H2O/10% D2O	90% H2O/10% D2O	0.12	6.5	ambient	293
9	3D HCCH-TOCSY	100mM sodium chloride-3; 20mM sodium phosphate-4; 100% D2O	100% D2O	0.12	6.5	ambient	293
10	3D HCCH-COSY	100mM sodium chloride-3; 20mM sodium phosphate-4; 100% D2O	100% D2O	0.12	6.5	ambient	293
11	3D 1H-13C NOESY	100mM sodium chloride-3; 20mM sodium phosphate-4; 100% D2O	100% D2O	0.12	6.5	ambient	293
12	3D 1H-15N NOESY	100mM sodium chloride-1; 20mM sodium phosphate-2; 90% H2O/10% D2O	90% H2O/10% D2O	0.12	6.5	ambient	293

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DMX	500

NMR Refinement
Method	Details	Software
simulated annealing		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift calculation	CYANA		Guntert, Mumenthaler and Wuthrich
2	refinement	CYANA		Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.